Precision Medicine & Health Equity
Immunotherapy in Cancer
September 23, 2016 in Atlanta, GA | #PrecisionMedicine
The 21st Annual HeLa Women's Health Symposium titled “Precision Medicine & Health Equity: Immunotherapy in Cancer,” focuses on immunotherapies which are one of the most important cancer research advances in decades, and this endeavor takes steps towards increasing personalized cancer care. Our Symposium will address research, clinical and health advocacy through our general session presentations and will take into account the importance of achieving health equity through the advancements made by these innovative approaches in cancer and beyond. A special program is developed for students around growing our pipeline and also includes a “Lunch and Learn with the Lacks Family.”
Practitioners, researchers, public policy and health advocates whose work and interest include disease prevention and treatment approaches where individual variability in genes, environment, and lifestyle are taken in account to achieve health equity, especially in women's health.
At the conclusion of the conference, participants should be able to:
- Define elements of the patients' immune system which is normally geared to rejection of foreign invaders such as viruses or transformed neoplastic cells;
- Identify tumor agents which promote expression of transformed normal cells (the transforming agent may be viral, bacterial or chemical mutations, or molecular biologic mutation); and
- Recognize specific pathways for definition of specific mechanisms of chemotherapeutic and Immunotherapeutic values.
The Morehouse School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The Morehouse School of Medicine designates this live activity for a maximum of up to 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent to their participation in the activity.